2018, Generic Medicine and Labelling

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2018

Generic Medicine

Labelling

Drug Repurposing: Unlocking access to rare solutions

Express Pharma

NOVEMBER 1, 2024

The FDA’s 505(b)(2) pathway and the European Medicines Agency’s (EMA) Hybrid Pathway offer routes for drug developers to rely on previously submitted clinical data, cutting down approval times significantly. As the world’s largest manufacturer of generic medicines, India has vast potential to utilise repurposed drugs.

Drug Development

Drug Development Compounding Generic Medicine Vaccines

World Standards Day: Recognizing How Standards Enable a Strong Medicines Supply Chain

Quality Matters

OCTOBER 13, 2021

With this extensive system in place, patients can trust that medicines with the same name will be consistent in quality no matter who manufactures it or where in the world it is made. Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient.

Pharmaceutical Manufacturing

Pharmaceutical Manufacturing Adverse Reactions Prescription Filling Compounding

Pharmacist Digest

Drug Repurposing: Unlocking access to rare solutions

World Standards Day: Recognizing How Standards Enable a Strong Medicines Supply Chain

Stay Connected